NASDAQ: INCR
Intercure Ltd Stock Ownership - Who owns Intercure?

Insider buying vs selling

Have Intercure Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when INCR insiders and whales buy or sell their stock.

INCR Shareholders

What type of owners hold Intercure Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Goldman Sachs Group Inc2.68%1,262,726$1.17MInstitution
Jane Street Group LLC0.45%214,253$198.18kInstitution
Healthcare Of Ontario Pension Plan Trust Fund0.45%212,500$196.56kInstitution
Advisorshares Investments LLC0.23%108,884$100.72kInstitution
Moore Capital Management LP0.21%97,273$89.98kInstitution
Renaissance Technologies LLC0.14%63,700$58.92kInstitution
Stonex Group Inc0.11%49,541$45.83kInstitution
Blackrock Inc0.05%24,162$22.35kInstitution
Geode Capital Management LLC0.05%22,539$20.85kInstitution
Citadel Advisors LLC0.03%12,775$11.82kInstitution

1 of 3

INCR vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INCR4.47%0.00%
RMTI8.46%91.54%Net SellingNet Selling
TLPH25.53%74.47%Net Buying
ZYBT0.33%0.00%
SCYX28.05%21.55%Net Buying

Intercure Stock Ownership FAQ

Who owns Intercure?

Intercure (NASDAQ: INCR) is owned by 4.47% institutional shareholders, 0.00% Intercure insiders, and 95.53% retail investors. Goldman Sachs Group Inc is the largest individual Intercure shareholder, owning 1.26M shares representing 2.68% of the company. Goldman Sachs Group Inc's Intercure shares are currently valued at $1.18M.

If you're new to stock investing, here's how to buy Intercure stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.